Session Details
[P-NR](-)RNA
Thu. Oct 31, 2019 9:00 AM - 12:00 PM JST
Thu. Oct 31, 2019 12:00 AM - 3:00 AM UTC
Thu. Oct 31, 2019 12:00 AM - 3:00 AM UTC
Poster Room Exhibition Hall
Viewing
[P-NR-01]Molecular Epidemiology of Measles Virus from Measles Outbreak in the Philippines, 2017-2018
*Leonibel Agajona Reyes1, Daniel Castro Villarico1, Jhulie Anne Petalino Mangurali1, Chrissa Myrh Galarosa Fuentes1 (1. Virology Department- Research Institute for Tropical Medicine)
[P-NR-02]Clinical value of biochemical feature for patients with measles in secondary vaccine failure
*Takako Kurata1, Daiki Kanbayashi1, Jun Komano2, Kazushi Motomura1 (1. Osaka Institute of Public Health, 2. Osaka University of Pharmaceutical Sciences)
[P-NR-03]Evaluation of humoral and cellular immune responses after mumps vaccination and protective activities against mumps virus challenges in a common marmoset model
*Fumihiro Kato1, Yasushi Ami1, Hiroshi Katoh1, Keiko Murano1, Yuriko Suzaki1, Noriyo Nagata1, Naoko Iwata1, Hideki Hasegawa1, Makoto Takeda1, Minoru Kidokoro1 (1. National Institute of Infectious Diseases)
[P-NR-04]Role of mumps virus V protein in production of infectious viral particles – another function independent of innate immunity antagonistic activity
*Hiroshi Katoh1, Yuichiro Nakatsu1, Fumihiro Kato1, Toshiyuki Yamaji1, Minoru Kidokoro1, Makoto Takeda1 (1. National Institute of Infectious Diseases)
[P-NR-05]Molecular epidemiology of Human Respiratory Syncytial Virus and Human metapneumovirus in Aichi Prefecture
*Hirokazu Adachi1, Emi Hirose1, Noriko Nakamura1, Noriko Saito1, Miyabi Ito1, Hiroko Minagawa1, Yoshihiro Yasui1 (1. Aichi Prefectural Institute of Public Health)
[P-NR-06]The inhibition mechanism of RS virus infection by maoto
*Aya Fujikane1, Atsuhiko Sakamoto1, Kenji HIromatsu2, Shigeki Nabeshima1 (1. General Medicine, Fukuoka University Hospital, 2. Department of Microbiology and Immunology, Fukuoka University School of Medicine)
[P-NR-07]Establishment of a recombinant attenuated vaccinia virus, LC16m8, expressing nipah virus surface glycoproteins.
*Shumpei Watanabe1,2, Tomoki Yoshikawa2, Takeshi Kurosu2, Shuetsu Fukushi2, Yoshihiro Kaku3, Shigeru Morikawa1,3, Masayuki Shimojima2, Masayuki Saijo2 (1. Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, 2. Department of Virology I, National Institute of Infectious Diseases, 3. Department of Veterinary Science, National Institute of Infectious Diseases)
[P-NR-08]Antiviral screening of 8000 extracts of plants against mumps virus
*Toshihito Nomura1, Kosuke Oda1, Masaya Fukushi1, Takashi Irie1, Takemasa Sakaguchi1 (1. Department of Virology Institute of Biomedical and Health Sciences Hiroshima University)
[P-NR-09]Antivirus drug screening targeting for Paramyxovirus C protein
*Kosuke Oda1, Toshihito Nomura1, Kiyohito Kihira2, Takayoshi Okabe3, Akifumi Higashiura1, Yasuyuki Matoba4, Takemasa Sakaguchi1 (1. Hiroshima university, 2. JAXA, 3. Drug Discovery Initiative, the University of Tokyo, 4. Yasuda women's university)
[P-NR-10]C gene knockout Sendai virus activates the phagocytosis in infected RAW264.7 macrophages
*Naoko Morita1, Yukie Tanaka2, Kenji Takeuchi2, Yoshikazu Naiki1, Naoki Koide1, Takayuki Komatsu1 (1. Aichi Medical University School of Medicine, 2. University of Fukui)
[P-NR-11]C gene knockout Sendai virus induces the secretion of IL-1β by facilitaing NLRP3 inflammasome assembly
*Takayuki Komatsu1, Yukie Tanaka2, Kenji Takeuchi2, Naoko Morita1, Yoshikazu Naiki1, Naoki Koide1 (1. Aichi Medical University, 2. University of Fukui)
[P-NR-12]Screening and validation of a biomarker candidate applicable to preclinical diagnosis of rabies
*Kentaro Yamada1,2, Koji Kuribayashi2, Naotaka Inomata2, Ryo Kaimori2, Kimitsuki Kazunori2, Nobuo Saito2, Akira Nishizono1,2 (1. Research Promotion Institute, Oita University, 2. Department Microbiology, Oita University)
[P-NR-13]Identification of small molecular compounds with potent anti-rabies virus activity
*Kentaro Uemura1,2, Shinsuke Toba1,2, Haruaki Nobori1, Ryu Yoshida1, Takao Shishido1, Michihito Sasaki2, Naoto Ito3, Yasuko Orba2, Hirofumi Sawa2,4, Akihiko Sato1,2 (1. Drug Discovery & Disease Research Laboratory, SHIONOGI & CO., LTD., 2. Research Center for Zoonosis Control, Hokkaido University, 3. Fuculty of Applied Biological Sciences, Gifu University, 4. GI-CoRE, Hokkaido University)
[P-NR-14]Induction of neutralizing antibodies against Bas-Congo virus using hydrogen peroxide-inactivated pseudotyped virus
*Eunsil Park1, Yoshihiro Kaku1, Akira Noguchi1, Ken Maeda1, Shigeru Morikawa1,2 (1. National Institute of Infectious Diseases, Department of Veterinary Science, 2. Okayama University, Laboratory of Veterinary Microbiology)
[P-NR-15]A surrogate animal model of filovirus infection using recombinant vesicular stomatitis virus pseudotyped with filovirus glycoproteins
*Takeshi SAITO1, Mao ISONO1, Yurie Kida1, Junki Maruyama2, Ayato Takada1 (1. Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, 2. Department of Pathology, The University of Texas Medical Branch)
[P-NR-16]Amino acid residues of Ebola virus nucleoprotein important for formation of nucleoprotein-RNA complex and functional nucleocapsid
*kazuya Houri1, Fujita Yoko1, Sugita Yukihiko2, Muramoto Yukiko1, Hu Shangfan1, Miyamoto sho1, Nakano Masahiro1, Matthias Wolf3, Noda Takeshi1 (1. Institute for Frontier Life and Medical Sciences, Kyoto University, 2. Institute for Protein Research, Osaka University, 3. Okinawa Institute of Science and Technology Graduate University)
[P-NR-17]Outbreak of avian bornaviruses in pet bird breeding facilities in Japan
*Yuto Watanabe1,2, Ryo Komorizono1,2, Madoka Sakai1,2, Mako Yanai1,2, Reiko Soga1,3, Junichi Kamiie4, Chinatsu Fujiwara4, Naoyuki Aihara4, Akiko Makino1,2, Keizo Tomonaga1,2,5 (1. Laboratory of RNA viruses, Department of Virus Research, Institute for Frontier Life and Medical sciences, Kyoto University, 2. Laboratory of RNA viruses, Department of Mammalian Regulatory Network, Graduate school of Bioscience, Kyoto University, 3. GROWWING ANIMAL HOSPITAL, 4. Laboratory of Veterinary Pathology, Department of Veterinary Medicine, School of Veterinary Medicine, Azabu University, 5. Department of Molecular Virology, Graduate School of Medicine, Kyoto University)
[P-NR-18]Transcriptional profiling of cell lines and tissues from bats of genus Eptesicus
*Hsien-Hen Lin1,2, Yahiro Mukai1,2, Keizo Tomonaga1,2,3, Masayuki Horie1,4 (1. Lab. of RNA Viruses, Dept. of Virus Research, Inst. for Frontier Life and Medical Sciences (InFRONT), Kyoto Univ., Kyoto, Japan, 2. Dept. of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto Univ., Kyoto, Japan., 3. Dept. of Molecular Virology, Graduate School of Medicine, Kyoto Univ., Kyoto, Japan., 4. Hakubi Center for Advanced Research, Kyoto Univ., Kyoto, Japan.)
[P-NR-19]Effects of pre-administration of corticosterone on Borna disease virus infection.
*Ren tachibana1, Ayato Fukada1, Yuki Kubota1, Takashi Kimura2, Yoshii Nishino1 (1. Kyoto Sangyo University, 2. Hokkaido University)
[P-NR-20]Corticosterone induces behavioral abnormality in the mice acute infected with mammalian 1 borna virus.
*ayato fukada1, naoki kawakita1, maho kitamura1, eri kidowaki1, dai yamada1, ren tatibana1, yuuki kubota1, tosiyuki saitou1, yosii nishino1 (1. Kyoto Sangyo University)
[P-NR-21]Analysis of Lymphocytic choriomeningitis virus replication in MDCK cells
*Shangfan Hu1,2, Junichi Kajikawa1,2, Shuzo Urata3,4, Jiro Yasuda3,4, Masahiro Nakano1,2, Yukiko Muramoto1,2, Takeshi Noda1,2 (1. Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, 2. Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, 3. Department of Emerging Infectious Diseases, Institute of Tropical Medicine(NEKKEN), Nagasaki University, 4. National Research Center for the Control and Prevention of infectious Diseases(CCPID),Nagasaki University)
[P-NR-22]In vivo pharmacokinetics and pharmacodynamics of compound X in a murine model for lymphocytic choriomeningitis virus infection
*Shinsuke Toba1,4, Haruaki Nobori1, Kentaro Uemura1,4, Yoshiyuki Taoda2, Kenji Satou3, Ryu Yoshida1, Takao Shishido1, Yasuko Orba4, Hirofumi Sawa4,5, Akihiko Sato1,4 (1. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., 2. Medicinal Chemistry Research Laboratory, Shionogi & Co., Ltd., 3. Research Laboratory for Development, Shionogi & Co., Ltd., 4. Research Center for Zoonosis Control, Hokkaido University, 5. Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University)
[P-NR-23]Screening of small chemical compounds able to inhibit Lujo virus cell-entry
*Risa Matsuoka1, Miyuki Kimura1, Takasuke Fukuhara2, Yoshiharu Matsuura2, Masayuki Saijo3, Hideki Tani1 (1. Department of Virology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, 3. Department of Virology I, National Institute of Infectious Diseases)
[P-NR-24]Identification of a novel phlebovirus gene in Ixodes persulcatus and Haemaphysalis flava collected in Hokkaido, Japan
*Leo Uchida1, Yuna Koyanagi1, Yasukazu Muramatsu1 (1. Rakuno Gakuen University)
[P-NR-25]Development of Serodiagnostic method of Soricomorpha-borne hantaviruses, Thottapalayam, Asama, Seewis and Altai viruses
*Wei Zhuoxing1, Kenta Shimizu5,2, Kumpei Nishigami, Yoshimi Tsuda2,5, Chandika D. Gamage3, Jiro Arikawa5, Satoru Arai4, Kumiko Yoshimatsu1,5 (1. Graduate School of Infectious Diseases, Hokkaido University, 2. Graduate School of Medicine, Hokkaido University, 3. Department of Microbiology, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka, 4. National Institute of Infectious Diseases, Tokyo, Japan, 5. Faculty of Medicine, Hokkaido University)
[P-NR-26]Atypical lymphocytes transiently appear in the peripheral blood of patients with severe fever with thrombocytopenia syndrome are plasmablasts
*Toru Takahashi1, Tadaki Suzuki2, Harutaka katano2, Yuko Sato2, Hideki Hasegawa2, Shota Nono1, Takuro Matsumura1, Kohei Sakai1, Takayuki Tominaga1 (1. Yamaguchi Grand Medical Center, 2. National Institute of Infectious Diseases)
[P-NR-27]Minigenome-based reporter system suitable for high-throughput screening of small compounds able to inhibit replication and/or transcription of SFTSV
*Hiroshi Yamada1, Miyuki Kimura1, Long Tan1, Satoshi Taniguchi2, Masayuki Shimojima2, Takasuke Fukuhara3, Yoshiharu Matsuura3, Takashi Komeno4, Nozomi Nakajima4, Yousuke Furuta5, Masayuki Saijo2, Hideki Tani1 (1. University of Toyama, 2. National Institute of Infectious Diseases, 3. Osaka University, 4. FUJIFILM Toyama Chemical Co., Ltd, 5. FUJIFILM Corporation)
[P-NR-28]Development of an RT-LAMP assay for the rapid detection of SFTS virus
*Shiori Sano1, Shuetsu Fukushi2, Souichi Yamada2, Shizuko Harada2, Tomoki Yoshikawa2, Takeshi Kurosu2, Masayuki Shimojima2, Masayuki Saijo2 (1. EIKEN CHEMICAL Co., LTD., 2. Department of Virology I, National Institute of Infectious Diseases)
[P-NR-29]Favipiravir-susceptibility of severe fever with thrombocytopenia syndrome (SFTS) virus isolated from fatal SFTS patients treated with favipiravir
*Masaaki Satoh1, Hirofumi Kato1, Mutsuyo Ito-Takayama1, Shuetsu Fukushi1, Masayuki Shimojima1, Masaki Yasukawa2, Masayuki Saijo 1 (1. National Institute of Infectious Diseases, 2. Ehime University Graduate School of Medicine)
[P-NR-30]Evaluation of in vitro antiviral effect of favipiravir on the replication of the different genotypes of severe fever with thrombocytopenia syndrome virus
*Hirofumi Kato1, Mutsuyo Takayama-Ito1, Masaaki Satoh1, Hitomi Kinoshita1, Masayuki Shimojima1, Shuetsu Fukushi1, Tomoki Yoshikawa1, Takeshi Kurosu1, Nozomi Nakajima2, Takashi Komeno2, Yousuke Furuta3, Masayuki Saijo1 (1. Department of Virology 1, National Institute of Infectious Diseases, 2. Bio Science & Engineering Research Laboratories, Research and Development Management Headquarters, FUJIFILM Corporation, 3. FUJIFILM Toyama Chemical Co., Ltd.)
[P-NR-31]Attempt to make severe fever with thrombocytopenia syndrome virus (SFTSV) resistant to favipiravir
*Mutsuyo Takayama Ito1, Masaaki Sato1, Hirofumi Kato1, Kinoshita Hitomi 1, Masayuki Shimojima1, Shuetsu Fukushi1, Tomoki Yoshikawa1, Takeshi Kurosu1, Nozomi Nakajima2, Takashi Komeno2, Yousuke Furuta3, Masayuki Saijo1 (1. 1)Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan, 2. Bio Science & Engineering Research Laboratories, Research & Development Management Headquarters, FUJIFILM Corporation Toyama, Japan, 3. UJIFILM Toyama Chemical Co., Ltd., Toyama, Japan)
[P-NR-32]Establishment of a lethal model of Heartland virus infection in mice and evaluation of the efficacy of ribavirin and T-705 by using the model
*Hikaru Fujii Fujii1,2, Hideki Tani2,3, Satoshi Taniguchi2, Tomoki Yoshikawa2, Shuetsu Fukushi2, Souichi Yamada2, Shizuko Harada2, Chang-Kweng Lim2, Mutsuyo Takayama Ito2, Takahiro Maeki2, Takeshi Kurosu2, Masayuki Shimojima2, Akihiko Uda4, Takashi Komeno5, Nozomi Nakajima5, Yousuke Furuta6, Shigeru Morikawa1,4, Masayuki Saijo2 (1. Faculty of Veterinary Medicine, Okayama University of Science, 2. Depertment of Virology I, National Institute of Infectious Disease, 3. Department of Virology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 4. Department of Veterinary Science, National Institute of Infectious Diseases, 5. FUJIFILM Corporation, Bio Science & Engineering Research Laboratories, Research & Development Management Headquarters, 6. FUJIFILM Toyama Chemical Co., Ltd.)
[P-NR-33]Generation of single-round infectious particles of severe fever with thrombocytopenia syndrome virus
Long Tan1, Hiroshi Yamada1, Miyuki Kimura1, Satoshi Taniguchi2, Masayuki Shimojima2, Shuetsu Fukushi2, Shigeru Morikawa3, Masayuki Saijo2, *Hideki Tani1 (1. Department of Virology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2. Department of Virology I, National Institute of Infectious Diseases, 3. Faculty of Veterinary Medicine, Okayama University of Science)
[P-NR-34]Investigation of host proteins interacting with nucleocapsid protein of severe fever with thrombocytopenia syndrome virus
*Yuji Wada1,2, Benjamin Brennan2, Alain Kohl2, Kaori Sano1, Akira Ainai1, Hideki Hasegawa1, Tadaki Suzuki1 (1. Department of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan, 2. MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom)
[P-NR-35]Studies on the intracellular trafficking of nucleocapsid protein of severe fever with thrombocytopenia syndrome virus
*Kodai Ikekame1, Yoshimi Tsuda2, Kenta Shimizu2, Hiroaki Kariwa3, Jiro Arikawa2, Kumiko Yoshimatsu2 (1. Department of Microbiology and Immunology, Graduated School of Medicine. Hokkaido University, 2. Department of Microbiology and Immunology, Faculty of medicine, Hokkaido University, 3. Laboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University)